Inge R. Konings

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands

Christel J.M. de Blok, Chantal M Wiepjes, Nienke M. Nota et al. · BMJ · 2019 · 346 citations · Full text

Primary outcome analysis of the phase 3 SONIA trial (BOOG 2017-03) on selecting the optimal position of cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC).

Gabe S. Sonke, Annemiek van Ommen‐Nijhof, Noor Wortelboer et al. · Journal of Clinical Oncology · 2023 · 89 citations

First-line Use, Breast Oncology, Clinical Endpoint +23

Five new cases of breast cancer in transsexual persons

Louis Gooren, Mindy A Bowers, Paul Lips et al. · Andrologia · 2015 · 85 citations

Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer

Kathelijn S. Versteeg, S. Blauwhoff-Buskermolen, Laurien M. Buffart et al. · The Oncologist · 2017 · 81 citations · Full text

‘Oncokompas’, a web-based self-management application to support patient activation and optimal supportive care: a feasibility study among breast cancer survivors

Heleen C. Melissant, Irma M. Verdonck‐de Leeuw, Birgit I. Lissenberg‐Witte et al. · Acta Oncologica · 2018 · 76 citations · Full text